$218.11 +2.32 (1.075%) Synageva BioPharma Corp - NASDAQ

May. 22, 2015 | 04:00 PM

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
2/18/2014BOESS CARSTENSVP, Chief Financial Officer-1,745$103.05-66.12%
2/18/2014BOESS CARSTENSVP, Chief Financial Officer-3,207$102.18-54.86%
2/18/2014BOESS CARSTENSVP, Chief Financial Officer-3,081$101.14-34.51%
2/18/2014BOESS CARSTENSVP, Chief Financial Officer-1,000$100.07-10.07%
1/29/2014Patel Sanj KPresident & CEO50,971$3.524,943.84%
1/29/2014Patel Sanj KPresident & CEO-24,817$87.19-47.72%
1/29/2014Patel Sanj KPresident & CEO-18,652$88.31-68.61%
1/29/2014Patel Sanj KPresident & CEO-5,600$89.27-65.63%
1/29/2014Patel Sanj KPresident & CEO-1,502$90.85-51.21%
1/29/2014Patel Sanj KPresident & CEO-400$91.58-27.95%
1/28/2014Patel Sanj KPresident & CEO6,106$0.95592.24%
1/28/2014Patel Sanj KPresident & CEO24,832$3.52347.93%
1/28/2014Patel Sanj KPresident & CEO20,391$1.7063.78%
1/28/2014Patel Sanj KPresident & CEO-9,506$87.16-18.16%
1/28/2014Patel Sanj KPresident & CEO-32,609$88.38-76.09%
1/28/2014Patel Sanj KPresident & CEO-8,402$88.95-82.01%
1/28/2014Patel Sanj KPresident & CEO-812$90.10-44.06%
12/31/2013Quinn AnthonyEVP, CMO & Head of R&D192$36.301.25%
12/31/2013Williams GlenSVP, Technical Operations132$36.3098.51%
12/31/2013Goldberg Mark AlanEVP, Medical & Reg. Strategy192$36.3071.91%
12/03/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-6,587$60.49-90.64%
12/03/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-413$61.02-60.74%
12/02/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs7,000$8.732,621.72%
11/18/2013BOESS CARSTENSVP, Chief Financial Officer-3,861$53.98-38.89%
11/18/2013BOESS CARSTENSVP, Chief Financial Officer-1,765$54.97-29.10%
11/18/2013BOESS CARSTENSVP, Chief Financial Officer-3,801$55.99-88.37%
11/18/2013BOESS CARSTENSVP, Chief Financial Officer-500$57.20-100.00%
11/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs7,000$8.732,621.72%
11/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-3,695$49.61-50.85%
11/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-3,205$50.34-89.73%
11/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-100$51.04-27.25%
10/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs7,000$8.732,621.72%
10/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-3,230$63.97-44.45%
10/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-3,770$64.61-93.39%
9/25/2013BAKER FELIXSenior Executive Officer1,024,337$56.6315.10%
9/25/2013BAKER FELIXSenior Executive Officer25,663$56.6314.51%
8/21/2013BOESS CARSTENSVP, Chief Financial Officer-6,681$47.19-100.00%
8/20/2013BOESS CARSTENSVP, Chief Financial Officer2,173$23.0038.62%
8/20/2013BOESS CARSTENSVP, Chief Financial Officer-7,800$47.04-100.00%
8/16/2013BOESS CARSTENSVP, Chief Financial Officer-4,300$47.47-100.00%
7/29/2013Patel Sanj KPresident & CEO-15,895$47.39-93.91%
7/29/2013Patel Sanj KPresident & CEO15,895$3.521,541.71%
7/26/2013Patel Sanj KPresident & CEO35,308$3.52193.63%
7/26/2013Patel Sanj KPresident & CEO16,882$1.7031.53%
7/26/2013Patel Sanj KPresident & CEO-52,190$47.91-74.11%
7/26/2013Patel Sanj KPresident & CEO-17,204$48.31-94.35%
7/25/2013Patel Sanj KPresident & CEO-14,711$48.73-44.65%
7/25/2013Patel Sanj KPresident & CEO20,000$1.70154.49%
7/25/2013Patel Sanj KPresident & CEO3,664$0.9539.47%
7/25/2013Patel Sanj KPresident & CEO8,251$0.95800.29%
7/16/2013Heberlig ChrisVice President, Finance-2,029$48.26-100.00%
7/15/2013Heberlig ChrisVice President, Finance-495$49.15-19.61%
7/15/2013Heberlig ChrisVice President, Finance1,877$0.95290.11%
7/15/2013Heberlig ChrisVice President, Finance247$0.9561.75%
7/11/2013BOESS CARSTENSVP, Chief Financial Officer-13,237$47.06-100.00%
6/28/2013Quinn AnthonySVP, Chief Medical Officer297$35.681.98%
6/12/2013Patel Sanj KPresident & CEO-40,352$40.48-97.51%
6/12/2013Patel Sanj KPresident & CEO25,621$0.952,485.06%
6/12/2013Patel Sanj KPresident & CEO14,731$1.7055.27%
6/11/2013Patel Sanj KPresident & CEO-29,648$40.89-96.64%
6/11/2013Patel Sanj KPresident & CEO6,105$0.9524.84%
6/11/2013Patel Sanj KPresident & CEO23,543$0.952,283.51%
4/08/2013Patel Sanj KPresident & CEO-21,695$49.49-95.46%
4/08/2013Patel Sanj KPresident & CEO21,695$0.952,104.27%
4/05/2013Patel Sanj KPresident & CEO-9,910$50.11-90.58%
4/05/2013Patel Sanj KPresident & CEO9,910$0.95961.20%
4/04/2013Patel Sanj KPresident & CEO-1,200$51.64-53.79%
4/04/2013Patel Sanj KPresident & CEO-2,151$50.72-49.09%
4/04/2013Patel Sanj KPresident & CEO-18,580$50.12-80.92%
4/04/2013Patel Sanj KPresident & CEO21,931$0.952,127.16%
4/03/2013Patel Sanj KPresident & CEO-400$54.44-27.95%
4/03/2013Patel Sanj KPresident & CEO-1,500$53.37-51.18%
4/03/2013Patel Sanj KPresident & CEO-4,358$52.55-59.79%
4/03/2013Patel Sanj KPresident & CEO-10,206$51.09-58.34%
4/03/2013Patel Sanj KPresident & CEO7,000$0.9566.70%
4/03/2013Patel Sanj KPresident & CEO9,464$0.95917.94%
4/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-619$54.92-100.00%
4/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-3,797$54.21-85.98%
4/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs3,091$0.95233.28%
3/01/2013Goldberg Mark AlanSVP, Product Development-1,713$51.35-100.00%
3/01/2013Goldberg Mark AlanSVP, Product Development-2,704$50.39-61.22%
2/21/2013Patel Sanj KPresident & CEO45,392$0.954,402.72%
2/21/2013Patel Sanj KPresident & CEO-45,392$49.02-97.78%
2/20/2013Patel Sanj KPresident & CEO18,654$0.951,809.31%
2/20/2013Patel Sanj KPresident & CEO5,954$0.9530.25%
2/20/2013Patel Sanj KPresident & CEO-18,654$49.49-72.76%
2/20/2013Patel Sanj KPresident & CEO-5,954$49.60-85.24%
2/01/2013Goldberg Mark AlanSVP, Product Development-2,660$48.02-100.00%
2/01/2013Goldberg Mark AlanSVP, Product Development-1,757$47.33-39.78%
1/18/2013Quinn AnthonySVP, Chief Medical Officer-9,447$50.08-38.59%
1/18/2013Quinn AnthonySVP, Chief Medical Officer9,447$0.9562.83%
1/17/2013Quinn AnthonySVP, Chief Medical Officer200$0.951.33%
1/17/2013Quinn AnthonySVP, Chief Medical Officer-200$50.00-1.31%
1/16/2013BOESS CARSTENSVP, Chief Financial Officer-9,927$49.12-100.00%
1/16/2013Quinn AnthonySVP, Chief Medical Officer353$0.951.76%
1/16/2013Quinn AnthonySVP, Chief Medical Officer-5,353$50.07-26.26%
1/09/2013TISCH THOMAS JDirector21,039$47.535.97%
1/04/2013BAKER JULIANSenior Executive Officer20,099$47.5312.82%
1/04/2013BAKER JULIANSenior Executive Officer839,621$47.5314.13%
1/04/2013BAKER FELIXSenior Executive Officer20,099$47.5312.82%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (GEVA), click here.
  • Showing 101-200 of 293 items
  • <<
  • 1
  • 2
  • 3
  • >>
Trading Center